Cilostazol for intermittent claudication
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cilostazol for Intermittent Claudication." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed 20 April 2024.
Cilostazol for intermittent claudication. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review. Accessed April 20, 2024.
Cilostazol for intermittent claudication. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
Cilostazol for Intermittent Claudication [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cilostazol for intermittent claudication
ID - 433522
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age_related_macular_degeneration:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -